These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases. Wang Y; Long W; Cao Y; Li J; You L; Fan Y Biosci Rep; 2020 May; 40(5):. PubMed ID: 32320046 [TBL] [Abstract][Full Text] [Related]
11. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation. Ahn SY; Chang YS; Park WS J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779 [TBL] [Abstract][Full Text] [Related]
12. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy. Pierro M; Ciarmoli E; Thébaud B Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085 [TBL] [Abstract][Full Text] [Related]
13. Preventing Brain Damage from Hypoxic-Ischemic Encephalopathy in Neonates: Update on Mesenchymal Stromal Cells and Umbilical Cord Blood Cells. Nabetani M; Mukai T; Shintaku H Am J Perinatol; 2022 Dec; 39(16):1754-1763. PubMed ID: 33853147 [TBL] [Abstract][Full Text] [Related]
14. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia. O'Reilly M; Thébaud B Clin Perinatol; 2012 Sep; 39(3):703-25. PubMed ID: 22954277 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Applications of Extracellular Vesicles: Perspectives from Newborn Medicine. Willis GR; Kourembanas S; Mitsialis SA Methods Mol Biol; 2017; 1660():409-432. PubMed ID: 28828676 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial). Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282 [TBL] [Abstract][Full Text] [Related]
17. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia. Namba F Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104 [TBL] [Abstract][Full Text] [Related]
19. "Good things come in small packages": application of exosome-based therapeutics in neonatal lung injury. Willis GR; Mitsialis SA; Kourembanas S Pediatr Res; 2018 Jan; 83(1-2):298-307. PubMed ID: 28985201 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation. Lesage F; Thébaud B Cells; 2022 Mar; 11(7):. PubMed ID: 35406742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]